The helper function of anti-tumor CD4+ T-cells improves the efficacy of anti-tumor CD8+ T-cells; seen early on in studies where transfecting tumor cells with MHC class II genes resulted in increased anti-tumor immune responses [20,21]. Here, CD8A is linked to neoplasm.